全文获取类型
收费全文 | 1889篇 |
免费 | 172篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 37篇 |
妇产科学 | 31篇 |
基础医学 | 308篇 |
口腔科学 | 30篇 |
临床医学 | 199篇 |
内科学 | 463篇 |
皮肤病学 | 8篇 |
神经病学 | 131篇 |
特种医学 | 46篇 |
外科学 | 276篇 |
综合类 | 33篇 |
预防医学 | 246篇 |
眼科学 | 47篇 |
药学 | 104篇 |
肿瘤学 | 77篇 |
出版年
2021年 | 29篇 |
2020年 | 16篇 |
2019年 | 24篇 |
2018年 | 36篇 |
2017年 | 17篇 |
2016年 | 23篇 |
2015年 | 34篇 |
2014年 | 39篇 |
2013年 | 50篇 |
2012年 | 87篇 |
2011年 | 84篇 |
2010年 | 66篇 |
2009年 | 34篇 |
2008年 | 91篇 |
2007年 | 67篇 |
2006年 | 79篇 |
2005年 | 81篇 |
2004年 | 73篇 |
2003年 | 69篇 |
2002年 | 61篇 |
2001年 | 57篇 |
2000年 | 56篇 |
1999年 | 63篇 |
1998年 | 30篇 |
1997年 | 18篇 |
1996年 | 18篇 |
1995年 | 21篇 |
1994年 | 19篇 |
1993年 | 21篇 |
1992年 | 43篇 |
1991年 | 55篇 |
1990年 | 44篇 |
1989年 | 40篇 |
1988年 | 37篇 |
1987年 | 47篇 |
1986年 | 39篇 |
1985年 | 36篇 |
1984年 | 19篇 |
1983年 | 33篇 |
1982年 | 17篇 |
1980年 | 17篇 |
1979年 | 15篇 |
1978年 | 21篇 |
1977年 | 16篇 |
1976年 | 18篇 |
1974年 | 21篇 |
1973年 | 17篇 |
1972年 | 18篇 |
1971年 | 18篇 |
1970年 | 16篇 |
排序方式: 共有2063条查询结果,搜索用时 15 毫秒
991.
Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients 下载免费PDF全文
K.Y. Popiel P. Wong M.J. Lee M. Langelier D.C. Sheppard D.C. Vinh 《Transplant infectious disease》2015,17(3):435-441
Saccharomyces cerevisiae, an ascosporogenous yeast commonly used in the production of food, is an emerging infection in immunocompromised patients. We report the case of a 60‐year‐old man whose orthotopic liver transplant was complicated by S. cerevisiae fungemia and peritoneal abscess, successfully treated with caspofungin and drainage. We also review the literature of invasive saccharomycoses in recipients of hematologic and solid organ transplants. 相似文献
992.
993.
Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. 总被引:1,自引:1,他引:1 下载免费PDF全文
G. W. Ching J. A. Franklyn T. J. Stallard J. Daykin M. C. Sheppard M. D. Gammage 《Heart (British Cardiac Society)》1996,75(4):363-368
OBJECTIVES: To define the effects of long-term thyroxine treatment upon heart rate, blood pressure, left ventricular systolic function, and left ventricular size, as well as indices of autonomic function, and to compare findings with those in patients with thyrotoxicosis before and during treatment. DESIGN: Cross sectional study of patients prescribed thyroxine long term (n = 11), patients with thyrotoxicosis studied at presentation (n = 23), compared with controls (n = 25); longitudinal study of patients with thyrotoxicosis studied at presentation and serially after beginning antithyroid drug treatment (n = 23). METHODS: 24 h ambulatory monitoring of pulse and blood pressure, echocardiography, forearm plethysmography, and autonomic function tests. RESULTS: Long-term thyroxine treatment in doses that reduced serum thyrotrophin to below normal had no effect on blood pressure, heart rate, left ventricular systolic function or stroke volume index, but was associated with an 18.4% increase in left ventricular mass index (mean (SEM) 101.9 (3.09) g/m2 v controls 86.1 (4.61), P < 0.01). Thryoxine treatment, like thyrotoxicosis, had no effect on tests of autonomic function. Untreated thyrotoxicosis resulted in pronounced changes in systolic and diastolic blood pressure and an increase in heart rate during waking and sleep. Patients with thyrotoxicosis at presentation had an increase in left ventricular systolic function (ejection fraction 70.5 (1.66)% v 65.4 (1.79), P < 0.01; fractional shortening 40.4 (1.54)% v 35.6 (1.46), P < 0.01), increased stroke volume index (45.9 (2.4) ml/m2 v 36.6 (1.7), P < 0.001), and an increase in forearm blood flow, and decrease in vascular resistance. They had a similar degree of left ventricular hypertrophy to that associated with thyroxine treatment (99.3 (4.03) g/m2); all changes were corrected within 2 months by antithyroid drugs. CONCLUSIONS: The development of left ventricular hypertrophy in patients receiving thyroxine in the absence of significant changes in heart rate, blood pressure, and left ventricular systolic function is consistent with a direct trophic effect of thyroid hormone on the myocardium. The presence of left ventricular hypertrophy determines that further studies are essential to assess cardiovascular risk in patients taking thyroxine long term. 相似文献
994.
J A Franklyn T Lynam K Docherty D B Ramsden M C Sheppard 《The Journal of endocrinology》1986,108(1):43-47
Thyroid hormones may directly regulate gene expression in the anterior pituitary. In order to examine this possibility we have studied the effect of hypothyroidism in the rat on pituitary cytoplasmic concentrations of messenger RNA (mRNA) encoding thyrotrophin (TSH) beta and alpha subunits, prolactin and GH. We demonstrated a marked increase in TSH beta and alpha subunit mRNA, accompanied by a decrease in GH mRNA, in the hypothyroid state, changes largely reversed by thyroid hormone replacement. We have thus shown a direct influence of thyroid status on the pretranslational events occurring in pituitary hormone synthesis. The simultaneous rise in cytoplasmic TSH beta and alpha mRNA levels and fall in GH mRNA in hypothyroidism suggests that thyroid status exerts a differential effect on the expression of these genes. 相似文献
995.
Bruce R. Lester John R. Sheppard Miriam Burman Stephen B. Somkuti Frans L. Stassen 《Molecular and cellular endocrinology》1985,40(2-3):193-204
The molecular mechanism of desensitization of antidiuretic hormone receptors is not well understood. Preincubation of LLC-PK1 cells with lysine vasopressin (LVP) (10−6 M, 5 h) decreased subsequent LVP-stimulated cAMP accumulation in cells by 83% and reduced the Vmax of LVP-stimulated adenylate cyclase by 81%. Such preincubation also reduced by 90% the binding of [3H]LVP to both intact cells and isolated plasma membranes, suggesting a loss of vasopressin receptors. Both the reduction in cAMP response and the apparent loss of receptors showed similar dose and time dependence. Monensin (33 μM) did not alter [3H]LVP binding or stimulation of cAMP by LVP, nor did it prevent desensitization. However, membranes prepared from cells preincubated with LVP in the presence of monensin did not show a decrease in [3H]LVP binding. Forskolin preincubation, at 0.1, 1, 10 and 100 μM, did not alter [3H]LVP binding or accumulation of cellular cAMP by LVP, nor did it induce desensitization to LVP. Cells desensitized with varying LVP concentrations in the presence of 10 μM forskolin displayed the same loss of [3H]LVP binding and LVP responsiveness as observed in the absence of forskolin. LVP-desensitized cells, upon removal from LVP-containing medium, recovered cAMP responsiveness to LVP and specific binding of [3H]LVP at the same rate, achieving control levels after 50 h. Recovery was prevented by cycloheximide (25 μg/ml). These findings are consistent with a desensitization process involving LVPmediated receptor internalization, and a recovery process requiring protein synthesis. 相似文献
996.
997.
The discriminatory value of cardiorespiratory interactions in distinguishing awake from anaesthetised states: a randomised observational study 下载免费PDF全文
D. A. Kenwright A. Bernjak T. Draegni S. Dzeroski M. Entwistle M. Horvat P. Kvandal S. A. Landsverk P. V. E. McClintock B. Musizza J. Petrovčič J. Raeder L. W. Sheppard A. F. Smith T. Stankovski A. Stefanovska 《Anaesthesia》2015,70(12):1356-1368
Depth of anaesthesia monitors usually analyse cerebral function with or without other physiological signals; non‐invasive monitoring of the measured cardiorespiratory signals alone would offer a simple, practical alternative. We aimed to investigate whether such signals, analysed with novel, non‐linear dynamic methods, would distinguish between the awake and anaesthetised states. We recorded ECG, respiration, skin temperature, pulse and skin conductivity before and during general anaesthesia in 27 subjects in good cardiovascular health, randomly allocated to receive propofol or sevoflurane. Mean values, variability and dynamic interactions were determined. Respiratory rate (p = 0.0002), skin conductivity (p = 0.03) and skin temperature (p = 0.00006) changed with sevoflurane, and skin temperature (p = 0.0005) with propofol. Pulse transit time increased by 17% with sevoflurane (p = 0.02) and 11% with propofol (p = 0.007). Sevoflurane reduced the wavelet energy of heart (p = 0.0004) and respiratory (p = 0.02) rate variability at all frequencies, whereas propofol decreased only the heart rate variability below 0.021 Hz (p < 0.05). The phase coherence was reduced by both agents at frequencies below 0.145 Hz (p < 0.05), whereas the cardiorespiratory synchronisation time was increased (p < 0.05). A classification analysis based on an optimal set of discriminatory parameters distinguished with 95% success between the awake and anaesthetised states. We suggest that these results can contribute to the design of new monitors of anaesthetic depth based on cardiovascular signals alone. 相似文献
998.
999.
1000.
JM Tarkin N Hadjiloizou HO Savage SK Prasad MN Sheppard NE Moat S Kaddoura 《Cardiovascular journal of Africa》2012,23(7):e1-e3
Cardiac failure due to rapidly progressive valve disease is a rare complication of rheumatoid arthritis (RA) that can be challenging to manage. A patient with severe heart failure secondary to RA who, after failing to respond to medical therapy, underwent high-risk valve surgery and did remarkably well, with dramatic symptomatic improvement and essentially normalised left ventricular size and function as seen on follow-up echocardiography. 相似文献